https://www.selleckchem.com/products/ab680.html
The aim of this study was to compare the adherence, healthcare resource and cost implications of using Episenta® minitablets or Epilim® monolithic tablet in the treatment of epilepsy in children in England. This is a retrospective analysis of healthcare administrative databases. The study analysed data collected from Primary Care (Clinical Practice Research Datalink (CPRD)) and Secondary Care (Hospital Episode Statistics (HES)) in England, UK. Patients (stratified by age 0-12; 0-17 and 18+ years) with a diagnosis of epilepsy in receipt of
Like
Comment
Share
